^ 1.01.1Primary Biliary Cirrhosis: A 2010 Update. Journal of Hepatology. 2010, 52 (5): 745–758. PMID 20347176. doi:10.1016/j.jhep.2009.11.027.
^The Immunobiology and Pathophysiology of Primary Biliary Cirrhosis. Annual Review of Pathology. January 2013, 8: 303–330. PMID 23347352. doi:10.1146/annurev-pathol-020712-164014.
^Dancygier, Henryk. Principles and Practice of Clinical Hepatology. Springer. 2010: 895– [29 June 2010]. ISBN 978-3-642-04509-7. (原始内容于2021-11-02).
^Epidemiology of Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis: A Systematic Review. Journal of Hepatology. 2012, 56 (5): 1181–1188. PMID 22245904. doi:10.1016/j.jhep.2011.10.025.
^Primary Biliary Cirrhosis Once Rare, Now Common in the United Kingdom?. Hepatology. 1999, 30 (2): 390–394. PMID 10421645. doi:10.1002/hep.510300213. 引文格式1维护:显示-作者 (link)
^Dauphinee, James A.; Sinclair, Jonathan C. Primary Biliary Cirrhosis. Canadian Medical Association Journal. July 1949, 61 (1): 1–6. PMC 1591584. PMID 18153470.
^PBC Foundation (UK). PBC Name Change. [27 Jan 2017]. (原始内容于2017-02-02).
^To screen or not to screen? Celiac antibodies in liver diseases.. World J Gastroenterol (Review). 2017, 23 (5): 776–791. PMC 5296194. PMID 28223722. doi:10.3748/wjg.v23.i5.776.
^Celiac Disease in Autoimmune Cholestatic Liver disorders. The American Journal of Gastroenterology. October 2002, 97 (10): 2609–2613. PMID 12385447. 引文格式1维护:显示-作者 (link)
^Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants. The New England Journal of Medicine. June 2009, 360 (24): 2544–2555. PMC 2857316. PMID 19458352. doi:10.1056/NEJMoa0810440. 引文格式1维护:显示-作者 (link)
^UK-PBC – Stratified Medicine in Primary Biliary Cholangitis (PBC; formally known as Cirrhosis). [2022-04-09]. (原始内容于2021-06-24).
^Dense Fine-Mapping Study Identifies New Susceptibility Loci for Primary Biliary Cirrhosis. Nature Genetics. October 2012, 44 (10): 1137–1141. PMC 3459817. PMID 22961000. doi:10.1038/ng.2395. 引文格式1维护:显示-作者 (link)
^Immunochip Analyses Identify a Novel Risk Locus for Primary Biliary Cirrhosis at 13q14, Multiple Independent Associations at Four Established Risk Loci and Epistasis Between 1p31 and 7q32 Risk Variants. Human Molecular Genetics. December 2012, 21 (23): 5209–5221. PMC 3490520. PMID 22936693. doi:10.1093/hmg/dds359. 引文格式1维护:显示-作者 (link)
^POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33. Sci Rep. 2019, 9 (1): 102. Bibcode:2019NatSR...9..102H. PMC 6331557. PMID 30643196. doi:10.1038/s41598-018-36490-1.
^Patients with Primary Biliary Cirrhosis React Against a Ubiquitous Xenobiotic-Metabolizing Bacterium. Hepatology. November 2003, 38 (5): 1250–1257. PMID 14578864. doi:10.1053/jhep.2003.50446. 引文格式1维护:显示-作者 (link)
^Autoimmune Disease Triggered by Infection with Alphaproteobacteria. Expert Review of Clinical Immunology. July 2009, 5 (4): 369–379. PMC 2742979. PMID 20161124. doi:10.1586/ECI.09.23.
^Novosphingobium aromaticivorans: a Potential Initiator of Primary Biliary Cirrhosis. The American Journal of Gastroenterology. November 2004, 99 (11): 2147–2149. PMID 15554995.
^Bacteria and Human Autoimmunity: The Case of Primary Biliary Cirrhosis. Current Opinion in Rheumatology. July 2004, 16 (4): 406–410. PMID 15201604. doi:10.1097/01.bor.0000130538.76808.c2.
^Identification of Cd101 as a Susceptibility Gene for Novosphingobium aromaticivorans-induced Liver Autoimmunity. Journal of Immunology. July 2011, 187 (1): 337–349. PMC 3134939. PMID 21613619. doi:10.4049/jimmunol.1003525. 引文格式1维护:显示-作者 (link)
^Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology. March 2009, 49 (3): 871–9. PMC 2665925. PMID 19185000. doi:10.1002/hep.22736.
^Increased expression of Nuclear Envelope gp210 Antigen in Small Bile Ducts in Primary Biliary Cirrhosis. Journal of Autoimmunity. March 2006, 26 (2): 138–145. PMID 16337775. doi:10.1016/j.jaut.2005.10.007. 引文格式1维护:显示-作者 (link)
^Measurement of gp210 Autoantibodies in sera of Patients With Primary Biliary cirrhosis. Journal of Clinical Laboratory Analysis. 2007, 21 (4): 227–231. PMC 6648998. PMID 17621358. doi:10.1002/jcla.20170.
^Anti-gp210 and Anti-Centromere Antibodies Are Different Risk Factors for the Progression of Primary Biliary Cirrhosis. Hepatology. January 2007, 45 (1): 118–127. PMID 17187436. doi:10.1002/hep.21472. 引文格式1维护:显示-作者 (link)
^Anti-Nuclear Envelope Antibodies: Clinical Associations. Seminars in Arthritis and Rheumatism. April 2001, 30 (5): 313–320. PMID 11303304. doi:10.1053/sarh.2001.20266.